Literature DB >> 15787818

Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity.

V Quekenborn-Trinquet1, P Fogel, O Aldana-Jammayrac, P Ancian, M Demarchez, P Rossio, H L Richards, B Kirby, C Nguyen, J J Voegel, C E M Griffiths.   

Abstract

BACKGROUND: Psoriasis is characterized by symmetry of plaques and modulation of multiple genes within those plaques.
OBJECTIVES: We compared gene expression profiles of plaques of psoriasis at different anatomical sites for both symmetrical and asymmetrical disease to ascertain whether the same genes were expressed.
METHODS: Gene expression profiles were analysed in biopsies from lesional and uninvolved skin from two groups of patients with either predominantly symmetrical or truncal plaques of psoriasis vulgaris, and from normal skin of healthy volunteers. Genomic analyses were performed using cDNA array and kinetically monitored reverse transcriptase-initiated polymerase chain reaction (kRT-PCR) approaches. A cluster of genes upregulated in involved psoriasis skin as compared with normal skin was identified using each of these two technologies.
RESULTS: Clustering of patients based on their gene expression profile did not reveal any correlation with family history of psoriasis, age at onset or association of psoriasis with arthritis. There was no difference in gene expression profile between the type (symmetrical vs. truncal) or location (left vs. right side of body) of psoriatic plaques. Gene expression profiles of involved psoriatic skin analysed by kRT-PCR analysis did correlate with both global (Psoriasis Area and Severity Index) and local (erythema, desquamation and plaque elevation) clinical severity.
CONCLUSIONS: These results indicate that it may be feasible to analyse the molecular effects of pharmacological agents on psoriatic skin in 'minizone' protocols, that the obtained data can be correlated with clinical severity and that plaques of psoriasis in the same individual express the same genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15787818     DOI: 10.1111/j.1365-2133.2005.06384.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis.

Authors:  Franak M Batliwalla; Wentian Li; Christopher T Ritchlin; Xiangli Xiao; Max Brenner; Teresina Laragione; Tianmeng Shao; Robert Durham; Sunil Kemshetti; Edward Schwarz; Rodney Coe; Marlena Kern; Emily C Baechler; Timothy W Behrens; Peter K Gregersen; Pércio S Gulko
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

Review 2.  Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity.

Authors:  Manfred Kunz; Saleh M Ibrahim
Journal:  Mediators Inflamm       Date:  2009-10-26       Impact factor: 4.711

3.  Integrated network analysis of transcriptomic and proteomic data in psoriasis.

Authors:  Eleonora Piruzian; Sergey Bruskin; Alex Ishkin; Rustam Abdeev; Sergey Moshkovskii; Stanislav Melnik; Yuri Nikolsky; Tatiana Nikolskaya
Journal:  BMC Syst Biol       Date:  2010-04-08

Review 4.  Post-genomics and skin inflammation.

Authors:  Daniela Braconi; Giulia Bernardini; Annalisa Santucci
Journal:  Mediators Inflamm       Date:  2010-09-19       Impact factor: 4.711

5.  The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis.

Authors:  John B Mee; Claire M Johnson; Nilesh Morar; Frank Burslem; Richard W Groves
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

6.  A subset of methylated CpG sites differentiate psoriatic from normal skin.

Authors:  Elisha D O Roberson; Ying Liu; Caitriona Ryan; Cailin E Joyce; Shenghui Duan; Li Cao; Ann Martin; Wilson Liao; Alan Menter; Anne M Bowcock
Journal:  J Invest Dermatol       Date:  2011-11-10       Impact factor: 8.551

7.  Interleukin-18 expression and the response to treatment in patients with psoriasis.

Authors:  Hanaa Rasmy; Nancy Mikhael; Somaia Ismail
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

8.  Interleukin-18 expression and the response to treatment in patients with psoriasis.

Authors:  Hanaa Rasmy Mohamed Attia; Nancy Mikhael; Somaia Ismail
Journal:  Arch Med Sci       Date:  2010-12-29       Impact factor: 3.318

Review 9.  The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis.

Authors:  Athanasios Mavropoulos; Eirini I Rigopoulou; Christos Liaskos; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  Clin Dev Immunol       Date:  2013-09-12

10.  Study on Certain Biomarkers of Inflammation in Psoriasis Through "OMICS" Platforms.

Authors:  C Rodríguez-Cerdeira; A Molares-Vila; E Sánchez-Blanco; B Sánchez-Blanco
Journal:  Open Biochem J       Date:  2014-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.